Any person who contests denial, suspension, or revocation of a permit shall have an opportunity for a regulatory hearing before the Food and Drug Administration pursuant to subpart F of part 16 of this chapter. [41 FR 48269, Nov. 2, 1976, as amended at 42 FR 15676, Mar. 22, 1977]